|
| Press Releases |
|
 |
|
| Monday, November 30, 2020 |
|
|
Sino Biopharmaceutical Announces 2020 Third Quarterly Results |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, more info >> |
|
| Friday, August 28, 2020 |
|
|
Sino Biopharm Announces 2020 Interim Results |
| Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced its unaudited interim results for the six months ended 30 June 2020 (the "review period"). more info >> |
|
| Thursday, May 28, 2020 |
|
|
Sino Biopharmaceutical Announces 2020 First Quarterly Results |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2020 ("the review period"). more info >> |
|
| Tuesday, May 26, 2020 |
|
|
New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration |
| Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced that the new drug application of the anti PD-1 monoclonal antibody drug more info >> |
|
| Tuesday, May 19, 2020 |
|
|
Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed by Sino Biopharmaceutical and Akeso Accepted for Presentation at ASCO Annual Meeting |
| Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced that the abstracts on phase II study on clinical efficacy and safety of Penpulimab more info >> |
|
| Monday, March 30, 2020 |
|
|
Sino Biopharm Announces 2019 Annual Results |
| Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX: 1177), a leading, innovative research and development driven pharmaceutical conglomerate in the PRC, has announced its financial results for the year ended 31 December 2019 ("the year"). more info >> |
|
| Tuesday, January 21, 2020 |
|
|
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO |
| Novotech CRO the largest biotech CRO in the Asia-Pacific said the region has had a record year for number of studies, experienced world-class sites and investigators, and patient enrolment. more info >> |
|
| Tuesday, November 26, 2019 |
|
|
Sino Biopharmaceutical Announces 2019 Third Quarterly Results |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited third quarterly results for the nine months ended 30 September 2019 ("the review period"). more info >> |
|
| Thursday, August 29, 2019 |
|
|
Sino Biopharmaceutical Announces 2019 Interim Results |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced today its unaudited interim results for the six months ended 30 June 2019 (the "review period").
more info >> |
|
| Wednesday, May 22, 2019 |
|
|
Sino Biopharmaceutical Announces 2019 First Quarterly Results |
Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2019 ("the review period").
more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Q2 Metals Intercepts 179.6 Metres of Continuous Spodumene Pegmatite in Large Step-Out at the Cisco Lithium Project in Quebec, Canada
Mar 22, 2025 02:40 HKT/SGT
|
|
|
Raya Lebih Bermakna: Spritzer Sparkling's Raya 2025 Brings Fans Closer to Family and Stars 
Mar 22, 2025 01:54 HKT/SGT
|
|
|
China Medical System (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum
Mar 21, 2025 23:00 HKT/SGT
|
|
|
Sino Biopharm (1177.HK) Announces 2024 Annual Results
Mar 21, 2025 22:15 HKT/SGT
|
|
|
Summit Group Holds Iftar in Singapore for About 200 Migrant Workers, Including Bangladeshis
Mar 21, 2025 19:00 HKT/SGT
|
|
|
The 33rd China International Bicycle Fair 2025 Set to Grandly Open
Mar 21, 2025 17:00 HKT/SGT
|
|
|
Mitsubishi Shipbuilding Receives Additional Orders for Three Methanol-Fueled RORO Cargo Ships
Mar 21, 2025 17:48 JST
|
|
|
Xforce HEV Model Premieres in Thailand
Mar 21, 2025 16:09 JST
|
|
|
Jiangsu Horizon Chain Supermarket, a Supermarket and Convenience Store Chain Store Operator, Announces Its Global Offering and Listing of H Shares on the Main Board of the Hong Kong Stock Exchange
Mar 21, 2025 15:00 HKT/SGT
|
|
|
CTF Life Title-sponsors: 'Fencing Plus' Training Programme by Kai Tak Sports Initiative
Mar 21, 2025 12:01 HKT/SGT
|
|
|
The Executive Centre Expands Its Premium Portfolio in Singapore With a New Centre at Ocean Financial Centre
Mar 21, 2025 10:00 HKT/SGT
|
|
|
ULVAC Developing Next-Generation Dilution Refrigerator for Quantum Computing by 2026
Mar 21, 2025 10:30 JST
|
|
|
TRENDE Secures JPY 1.07 Billion Investment to Expand Renewable Energy Initiatives and Strategic Partnerships
Mar 21, 2025 07:00 HKT/SGT
|
|
|
GA-ASI Achieves EMAR/FR 145 Maintenance Organization Approval for MQ-9A and MQ-9B Platforms
Mar 21, 2025 01:00 HKT/SGT
|
|
|
Graphene Manufacturing Group Ltd. Announces Closing of Bought Deal Financing
Mar 20, 2025 23:09 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
